Mechanism of interference mediated by human parainfluenza virus type 3 infection. 2000

M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

Viral interference is characterized by the resistance of infected cells to infection by a challenge virus. Mechanisms of viral interference have not been characterized for human parainfluenza virus type 3 (HPF3), and the possible role of the neuraminidase (receptor-destroying) enzyme of the hemagglutinin-neuraminidase (HN) glycoprotein has not been assessed. To determine whether continual HN expression results in depletion of the viral receptors and thus prevents entry and cell fusion, we tested whether cells expressing wild-type HPF3 HN are resistant to viral infection. Stable expression of wild-type HN-green fluorescent protein (GFP) on cell membranes in different amounts allowed us to establish a correlation between the level of HN expression, the level of neuraminidase activity, and the level of protection from HPF3 infection. Cells with the highest levels of HN expression and neuraminidase activity on the cell surface were most resistant to infection by HPF3. To determine whether this resistance is attributable to the viral neuraminidase, we used a cloned variant HPF3 HN that has two amino acid alterations in HN leading to the loss of detectable neuraminidase activity. Cells expressing the neuraminidase-deficient variant HN-GFP were not protected from infection, despite expressing HN on their surface at levels even higher than the wild-type cell clones. Our results demonstrate that the HPF3 HN-mediated interference effect can be attributed to the presence of an active neuraminidase enzyme activity and provide the first definitive evidence that the mechanism for attachment interference by a paramyxovirus is attributable to the viral neuraminidase.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D010224 Parainfluenza Virus 3, Human A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia. Hemadsorption Virus 1,Human parainfluenza virus 3,Para-Influenza Virus Type 3,Parainfluenza Virus Type 3,Para Influenza Virus Type 3
D010253 Respirovirus Infections Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface. Infections, Respirovirus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014762 Viral Interference A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. Interference, Viral,Interferences, Viral,Viral Interferences
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
January 1980, Journal of medical virology,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
November 1980, Journal of medical microbiology,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
January 2021, mAbs,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
February 2008, Antiviral research,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
June 2002, Virology,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
March 2015, Angewandte Chemie (International ed. in English),
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
October 2022, The Pediatric infectious disease journal,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
May 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
December 1971, Journal of the American Veterinary Medical Association,
M A Horga, and G L Gusella, and O Greengard, and N Poltoratskaia, and M Porotto, and A Moscona
July 1994, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!